Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00206089
Status:
TERMINATED
Last Update Posted:
2010-11-15
First Post:
2005-09-13
Brief Title:
MelagatranXimelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Thromboembolism |
Keywords:
| Name | View |
|---|---|
| Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery | View |